CLINICAL_TRIALS
trial_result
· 2026-02-11
Clinical Trial Update: Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia [Phase 1]
Summary
Phase 1 trial assessing the food effect on pharmacokinetics of a once-weekly brexpiprazole formulation in schizophrenia. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2026-02-11